Apellis Pharmaceuticals Operating Expenses | APLS

Annual Operating Expenses Apellis Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
948 M	946 M	914 M	670 M	603 M	464 M	288 M	128 M	50.8 M	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
948 M	50.8 M	557 M

Quarterly Operating Expenses Apellis Pharmaceuticals

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
242 M	235 M	212 M	250 M	-	244 M	229 M	234 M	-	247 M	215 M	220 M	-	175 M	165 M	143 M	-	134 M	195 M	125 M	-	130 M	116 M	-	-	69.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
250 M	69.9 M	189 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
Фармсинтез LIFE	201 M	-	-	-	Russia
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Завод ДИОД DIOD	249 M	-	-	-	Russia
Aptose Biosciences APTO	24.7 M	-	-45.71 %	$ 1.2 M	Canada
Cleveland BioLabs, Inc. CBLI	2.85 M	-	-7.31 %	$ 49 M	USA
Five Prime Therapeutics, Inc. FPRX	106 M	-	-	$ 1.77 B	USA
Aravive ARAV	80 M	-	-13.39 %	$ 1.45 M	USA
Arena Pharmaceuticals ARNA	427 M	-	-6.81 %	$ 3.04 B	USA
Biofrontera AG BFRA	34.4 M	-	-8.24 %	$ 105 M	Germany
Catabasis Pharmaceuticals, Inc. CATB	37.4 M	-	-6.97 %	$ 657 M	USA
China Biologic Products Holdings, Inc. CBPO	149 M	-	1.68 %	$ 4.65 B	China
Flexion Therapeutics, Inc. FLXN	159 M	-	-	$ 459 M	USA
Heat Biologics, Inc. HTBX	27.9 M	-	-5.76 %	$ 99.8 M	USA
Kindred Biosciences, Inc. KIN	53.3 M	-	0.11 %	$ 419 M	USA
Shineco, Inc. TYHT	9.61 M	-	-3.90 %	$ 97.2 M	China
Intec Pharma Ltd NTEC	13.8 M	-	-12.45 %	$ 17.7 M	Israel
Progenity, Inc. PROG	176 M	-	-3.47 %	$ 164 M	USA
CTI BioPharma Corp. CTIC	47.8 M	-	-	$ 1.2 B	USA
Strongbridge Biopharma plc SBBP	71.7 M	-	1.52 %	$ 136 M	USA
Decibel Therapeutics DBTX	64 M	-	-	$ 123 M	USA
Seneca Biopharma, Inc. SNCA	10.7 M	-	-1.19 %	$ 28.7 M	USA
IVERIC bio ISEE	190 M	-	-	$ 5.51 B	USA
Myovant Sciences Ltd. MYOV	64.1 M	-	-0.04 %	$ 2.62 B	USA
Trean Insurance Group TIG	-121 K	-	-	$ 316 M	USA
Virpax Pharmaceuticals VRPX	12.1 M	-	-45.12 %	$ 2.85 M	USA
Metacrine MTCR	61.1 M	-	-	$ 24.2 M	USA
Celsion Corporation CLSN	14.7 M	-	-6.63 %	$ 13.9 M	USA
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
AnaptysBio ANAB	187 M	$ 56.8	0.94 %	$ 1.63 B	USA
Genfit SA GNFT	78.3 M	-	2.54 %	$ 160 B	France
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
BiondVax Pharmaceuticals Ltd. BVXV	78.4 M	-	0.74 %	$ 768 M	Israel
Abcam plc ABCM	170 M	-	-	$ 4.9 B	Britain
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Affimed N.V. AFMD	54 M	-	-34.95 %	$ 21.5 M	Germany
AnPac Bio-Medical Science Co., Ltd. ANPC	106 M	-	-1.58 %	$ 28.1 M	China
Celyad Oncology SA CYAD	26.2 M	-	-	$ 12.5 M	Belgium
Gracell Biotechnologies GRCL	214 M	-	-	$ 3.37 B	China
Galapagos NV GLPG	709 M	-	-	$ 1.83 B	Belgium
Teligent, Inc. TLGT	548 K	-	-13.85 %	$ 16.1 M	USA
Viela Bio, Inc. VIE	163 M	-	-	$ 2.91 B	USA
Applied Molecular Transport AMTI	127 M	-	-	$ 10.1 M	USA
Aphria Inc. APHA	188 M	-	-0.45 %	$ 4.87 B	Canada
Aerpio Pharmaceuticals, Inc. ARPO	21.3 M	-	-0.90 %	$ 104 M	USA